Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Zetia (ezetimibe) Tablets, 10 mg, MSP Singapore Company, NDA 21-445 Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore Company, Approval Zetia (ezetimibe) Tablets, MSP Singapore Co., Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corporation, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Inc., Package Change | Zetia (ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corporation, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Control Supplement | Zetia (ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Comparative Efficacy | Zetia (ezetimibe) Tablets, Schering Corp., Efficacy Supp. w/Clinical Data & Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corp., New or Modified Indication | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Comparative Efficacy Claim | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (ezetimibe) Tablets, Schering Corp., Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore Co. LLC., Manufacturing Change or Addition | Vytorin (ezetimibe/simvastatin) Tablets, MSP Singapore, Labeling Revision | Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision | Zetia (Ezetimibe) Tablets, Schering Corp., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   ACCUTANE | ARAVA | BEXTRA | CELEBREX | CRESTOR | MERIDIA | NEURONTIN | OXYCONTIN | PERMAX PROPULSID | REMICADE | REZULIN | SEREVENT | SERZONE | TAMOXIFEN | TYSABRI | VYTORIN | ZYPREXA A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem Corp.